NCT02758405View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine

0.125% Bupivacaine plus fentanyl 2mcg/ml

DRUG

Fentanyl

0.125% Bupivacaine plus fentanyl 2mcg/ml

DEVICE

Infusion pump

Infusion pump set to deliver programmed intermittent epidural boluses (PIEB) plus patient-controlled epidural analgesia (PCEA).

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT02758405 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2 | Biotech Hunter | Biotech Hunter